Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7206374

N[C@@H](CC(=O)O)C(=O)NC(CCC1CCCCC1)C(=O)OC(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 9/20 0.44
MMP1 P03956 7/20 0.44
MMP3 P08254 7/20 0.44
CASP1 P29466 1/20 0.41
LTA4H P09960 1/20 0.40
KLK7 P49862 1/20 0.39
NPY1R P25929 1/20 0.39
CASP3 P42574 1/20 0.38
CTSS P25774 3/20 0.37
MME P08473 1/20 0.37
ACE P12821 1/20 0.37
CPA1 P15085 1/20 0.37
ACE2 Q9BYF1 1/20 0.37
CTSB P07858 1/20 0.37
CTSK P43235 1/20 0.37
KIF11 P52732 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7205030 0.95 MMP2 (0.48) MMP2MMP1MMP3CASP1LTA4H
SCHEMBL7204995 0.86 MMP2 (0.50) MMP2MMP1MMP3LTA4HCTSS
Hydrochloric Acid SCHEMBL7205141 0.85 MMP2 (0.49) MMP2MMP1MMP3LTA4HCTSS
Aspartame SCHEMBL10765033 0.74 ALDH1A1 (0.57)
Trifluoroacetic Acid SCHEMBL7205084 0.74 MMP2 (0.53) MMP2MMP1MMP3CASP1LTA4H
SCHEMBL7852245 0.74 CTSS (0.52) MMP2MMP1MMP3CTSSCTSK
Trifluoroacetic Acid SCHEMBL7209972 0.72 CASP1 (0.44) CASP1CTSSCTSBCTSK
SCHEMBL29615970 0.72 LTA4H (0.61) MMP2MMP1MMP3LTA4HMME
SCHEMBL7205034 0.71 FNTA (0.37) MMP2MMP1MMP3KLK7KIF11
SCHEMBL7212756 0.70 KLK7 (0.36) MMP2MMP1MMP3KLK7CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1030831-A4 PROCESS FOR THE PREPARATION OF AZACYCLOALKYLALKANOYL PSEUDOTETRAPEPTIDES AVENTIS PHARM PROD INC (US) 2003-01-02 EP disclosed
US-6180759-B1 PREPARING AZACYCLOALKANOYLPSEUDOTETRAPEPTIDES COMPRISING COUPLING A DIPEPTIDE WITH A PSEUDODIPEPTIDE; FOR EXAMPLE, N-(N-ETHYL-N-(1-OXO-4-(4-PIPERIDINYL)BUTYL)GLYCYL)-(L)-ALPHA-ASPARTYL-3 -CYCLOHEXYL-(L)-ALANINEAMIDE; USE AS ANTICOAGULANTS AVENTIS PHARMACEUTICALS PRODUCTS INC. 2001-01-30 US disclosed
EP-1030831-A1 PROCESS FOR THE PREPARATION OF AZACYCLOALKYLALKANOYL PSEUDOTETRAPEPTIDES Aventis Pharmaceuticals Products Inc. (US) 2000-08-30 EP disclosed
WO-1999019294-A1 PROCESS FOR THE PREPARATION OF AZACYCLOALKYLALKANOYL PSEUDOTETRAPEPTIDES AVENTIS PHARMACEUTICALS PRODUCTS INC. LEGAL/PATENTS (US) 1999-04-22 WO disclosed